Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:NUS
CUSIP67018T10
Phone801-345-1000
Debt
Debt-to-Equity Ratio0.46
Current Ratio1.82
Quick Ratio1.19
Price-To-Earnings
Trailing P/E Ratio24.69
Forward P/E Ratio22.25
P/E Growth2.28
Sales & Book Value
Annual Sales$2.28 billion
Price / Sales1.96
Cash Flow$4.7645 per share
Price / Cash16.86
Book Value$13.40 per share
Price / Book5.99
Profitability
EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.74%
Return on Equity25.67%
Return on Assets11.66%
Miscellaneous
Employees4,700
Outstanding Shares55,610,000
Market Cap$4.43 billion
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Friday, August 3rd. Shareholders of record on Friday, August 31st will be paid a dividend of $0.365 per share on Wednesday, September 12th. This represents a $1.46 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Thursday, August 30th. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) released its quarterly earnings results on Thursday, August, 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.90 by $0.18. The company earned $704.19 million during the quarter, compared to analyst estimates of $642.16 million. Nu Skin Enterprises had a net margin of 5.74% and a return on equity of 25.67%. Nu Skin Enterprises's quarterly revenue was up 28.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.77 earnings per share. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share guidance of $3.66-3.81 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.72. The company issued revenue guidance of $2.63-2.67 billion, compared to the consensus revenue estimate of $2.53 billion.Nu Skin Enterprises also updated its Q3 guidance to $0.97-1.02 EPS.
What price target have analysts set for NUS?
5 brokers have issued 12-month target prices for Nu Skin Enterprises' stock. Their forecasts range from $70.00 to $98.00. On average, they anticipate Nu Skin Enterprises' share price to reach $83.40 in the next twelve months. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.
What is the consensus analysts' recommendation for Nu Skin Enterprises?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. According to Zacks Investment Research, "Nu Skin surpassed the industry in the past six months, backed by strong regional performance, as well as expanding sales leaders and customers globally. Notably, these upsides aided the second-quarter 2018 results, marking its third consecutive period of year-on-year top- and bottom-line increases. The stellar quarterly show also encouraged management to raise 2018 revenue and earnings projections. To sustain such solid trends, Nu Skin is on track with initiatives to enhance technological capabilities, along with well-knit product launches and marketing programs. However, the company has been struggling with declining gross margins for a while. Moreover, it remains exposed to significant currency risks resulting from international markets and stiff competition from the existence of strong peers and abundant product alternatives." (8/6/2018)
- 2. Pivotal Research analysts commented, "We think 2018 might be bigger than usual – for Repo which again, is not in guidance." (2/16/2018)
Who are some of Nu Skin Enterprises' key competitors?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 65)
- Mr. Ritch N. Wood, CEO & Director (Age 52)
- Mr. Ryan S. Napierski, Pres (Age 44)
- Mr. Mark H. Lawrence, Exec. VP & CFO
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)
Has Nu Skin Enterprises been receiving favorable news coverage?
Media coverage about NUS stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a media and rumor sentiment score of 0.14 on Accern's scale. They also gave news coverage about the company an impact score of 46.01 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Nu Skin Enterprises.
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.05%), Dimensional Fund Advisors LP (2.07%), Bank of New York Mellon Corp (1.47%), Renaissance Technologies LLC (1.46%), Wasatch Advisors Inc. (1.20%) and Schwab Charles Investment Management Inc. (0.84%). Company insiders that own Nu Skin Enterprises stock include Andrew D Lipman, D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which institutional investors are selling Nu Skin Enterprises stock?
NUS stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Laurion Capital Management LP, Millennium Management LLC, Mackay Shields LLC, Aristotle Capital Boston LLC, Federated Investors Inc. PA, Russell Investments Group Ltd. and Canada Pension Plan Investment Board. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.
Which institutional investors are buying Nu Skin Enterprises stock?
NUS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Renaissance Technologies LLC, Acadian Asset Management LLC, BNP Paribas Arbitrage SA, First Trust Advisors LP, OppenheimerFunds Inc., Intrinsic Edge Capital Management LLC and Los Angeles Capital Management & Equity Research Inc.. View Insider Buying and Selling for Nu Skin Enterprises.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $80.33.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $4.43 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
